ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Smallpox Vaccine Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-11K9614
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Smallpox Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Smallpox Vaccine Market Research Report 2025

Code: QYRE-Auto-11K9614
Report
August 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bavarian Nordic
CEL-SCI
Chimerix
EpiVax
Nanotherapeutics Inc
Oncovir Inc
SIGA Technologies
Symphogen
TapImmune
Tonix Pharmaceuticals Holding

Smallpox Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Smallpox Vaccine Market

Smallpox Vaccine Market

The global market for Smallpox Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Smallpox vaccine develops immunity and protect people from smallpox. This smallpox vaccine is made from the virus called Vaccinia.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Smallpox Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Smallpox Vaccine.
The Smallpox Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Smallpox Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Smallpox Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Smallpox Vaccine Market Report

Report Metric Details
Report Name Smallpox Vaccine Market
CAGR 5%
Segment by Type
  • First Generation
  • Second Generation
  • Third Generation
Segment by Application
  • Government Hospital And Program
  • Private Hospitals / Clinicss
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bavarian Nordic, CEL-SCI, Chimerix, EpiVax, Nanotherapeutics, Oncovir, SIGA Technologies, Symphogen, TapImmune, Tonix Pharmaceuticals Holding
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Smallpox Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Smallpox Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Smallpox Vaccine Market report?

Ans: The main players in the Smallpox Vaccine Market are Bavarian Nordic, CEL-SCI, Chimerix, EpiVax, Nanotherapeutics, Oncovir, SIGA Technologies, Symphogen, TapImmune, Tonix Pharmaceuticals Holding

What are the Application segmentation covered in the Smallpox Vaccine Market report?

Ans: The Applications covered in the Smallpox Vaccine Market report are Government Hospital And Program, Private Hospitals / Clinicss

What are the Type segmentation covered in the Smallpox Vaccine Market report?

Ans: The Types covered in the Smallpox Vaccine Market report are First Generation, Second Generation, Third Generation

1 Smallpox Vaccine Market Overview
1.1 Product Definition
1.2 Smallpox Vaccine by Type
1.2.1 Global Smallpox Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 First Generation
1.2.3 Second Generation
1.2.4 Third Generation
1.3 Smallpox Vaccine by Application
1.3.1 Global Smallpox Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Government Hospital And Program
1.3.3 Private Hospitals / Clinicss
1.4 Global Smallpox Vaccine Market Size Estimates and Forecasts
1.4.1 Global Smallpox Vaccine Revenue 2020-2031
1.4.2 Global Smallpox Vaccine Sales 2020-2031
1.4.3 Global Smallpox Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Smallpox Vaccine Market Competition by Manufacturers
2.1 Global Smallpox Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Smallpox Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Smallpox Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Smallpox Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Smallpox Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Smallpox Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Smallpox Vaccine, Date of Enter into This Industry
2.8 Global Smallpox Vaccine Market Competitive Situation and Trends
2.8.1 Global Smallpox Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Smallpox Vaccine Players Market Share by Revenue
2.8.3 Global Smallpox Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Smallpox Vaccine Market Scenario by Region
3.1 Global Smallpox Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Smallpox Vaccine Sales by Region: 2020-2031
3.2.1 Global Smallpox Vaccine Sales by Region: 2020-2025
3.2.2 Global Smallpox Vaccine Sales by Region: 2026-2031
3.3 Global Smallpox Vaccine Revenue by Region: 2020-2031
3.3.1 Global Smallpox Vaccine Revenue by Region: 2020-2025
3.3.2 Global Smallpox Vaccine Revenue by Region: 2026-2031
3.4 North America Smallpox Vaccine Market Facts & Figures by Country
3.4.1 North America Smallpox Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Smallpox Vaccine Sales by Country (2020-2031)
3.4.3 North America Smallpox Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Smallpox Vaccine Market Facts & Figures by Country
3.5.1 Europe Smallpox Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Smallpox Vaccine Sales by Country (2020-2031)
3.5.3 Europe Smallpox Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Smallpox Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Smallpox Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Smallpox Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Smallpox Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Smallpox Vaccine Market Facts & Figures by Country
3.7.1 Latin America Smallpox Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Smallpox Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Smallpox Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Smallpox Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Smallpox Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Smallpox Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Smallpox Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Smallpox Vaccine Sales by Type (2020-2031)
4.1.1 Global Smallpox Vaccine Sales by Type (2020-2025)
4.1.2 Global Smallpox Vaccine Sales by Type (2026-2031)
4.1.3 Global Smallpox Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Smallpox Vaccine Revenue by Type (2020-2031)
4.2.1 Global Smallpox Vaccine Revenue by Type (2020-2025)
4.2.2 Global Smallpox Vaccine Revenue by Type (2026-2031)
4.2.3 Global Smallpox Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Smallpox Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Smallpox Vaccine Sales by Application (2020-2031)
5.1.1 Global Smallpox Vaccine Sales by Application (2020-2025)
5.1.2 Global Smallpox Vaccine Sales by Application (2026-2031)
5.1.3 Global Smallpox Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Smallpox Vaccine Revenue by Application (2020-2031)
5.2.1 Global Smallpox Vaccine Revenue by Application (2020-2025)
5.2.2 Global Smallpox Vaccine Revenue by Application (2026-2031)
5.2.3 Global Smallpox Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Smallpox Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bavarian Nordic
6.1.1 Bavarian Nordic Company Information
6.1.2 Bavarian Nordic Description and Business Overview
6.1.3 Bavarian Nordic Smallpox Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bavarian Nordic Smallpox Vaccine Product Portfolio
6.1.5 Bavarian Nordic Recent Developments/Updates
6.2 CEL-SCI
6.2.1 CEL-SCI Company Information
6.2.2 CEL-SCI Description and Business Overview
6.2.3 CEL-SCI Smallpox Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CEL-SCI Smallpox Vaccine Product Portfolio
6.2.5 CEL-SCI Recent Developments/Updates
6.3 Chimerix
6.3.1 Chimerix Company Information
6.3.2 Chimerix Description and Business Overview
6.3.3 Chimerix Smallpox Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Chimerix Smallpox Vaccine Product Portfolio
6.3.5 Chimerix Recent Developments/Updates
6.4 EpiVax
6.4.1 EpiVax Company Information
6.4.2 EpiVax Description and Business Overview
6.4.3 EpiVax Smallpox Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 EpiVax Smallpox Vaccine Product Portfolio
6.4.5 EpiVax Recent Developments/Updates
6.5 Nanotherapeutics
6.5.1 Nanotherapeutics Company Information
6.5.2 Nanotherapeutics Description and Business Overview
6.5.3 Nanotherapeutics Smallpox Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nanotherapeutics Smallpox Vaccine Product Portfolio
6.5.5 Nanotherapeutics Recent Developments/Updates
6.6 Oncovir
6.6.1 Oncovir Company Information
6.6.2 Oncovir Description and Business Overview
6.6.3 Oncovir Smallpox Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Oncovir Smallpox Vaccine Product Portfolio
6.6.5 Oncovir Recent Developments/Updates
6.7 SIGA Technologies
6.7.1 SIGA Technologies Company Information
6.7.2 SIGA Technologies Description and Business Overview
6.7.3 SIGA Technologies Smallpox Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 SIGA Technologies Smallpox Vaccine Product Portfolio
6.7.5 SIGA Technologies Recent Developments/Updates
6.8 Symphogen
6.8.1 Symphogen Company Information
6.8.2 Symphogen Description and Business Overview
6.8.3 Symphogen Smallpox Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Symphogen Smallpox Vaccine Product Portfolio
6.8.5 Symphogen Recent Developments/Updates
6.9 TapImmune
6.9.1 TapImmune Company Information
6.9.2 TapImmune Description and Business Overview
6.9.3 TapImmune Smallpox Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 TapImmune Smallpox Vaccine Product Portfolio
6.9.5 TapImmune Recent Developments/Updates
6.10 Tonix Pharmaceuticals Holding
6.10.1 Tonix Pharmaceuticals Holding Company Information
6.10.2 Tonix Pharmaceuticals Holding Description and Business Overview
6.10.3 Tonix Pharmaceuticals Holding Smallpox Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Tonix Pharmaceuticals Holding Smallpox Vaccine Product Portfolio
6.10.5 Tonix Pharmaceuticals Holding Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Smallpox Vaccine Industry Chain Analysis
7.2 Smallpox Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Smallpox Vaccine Production Mode & Process Analysis
7.4 Smallpox Vaccine Sales and Marketing
7.4.1 Smallpox Vaccine Sales Channels
7.4.2 Smallpox Vaccine Distributors
7.5 Smallpox Vaccine Customer Analysis
8 Smallpox Vaccine Market Dynamics
8.1 Smallpox Vaccine Industry Trends
8.2 Smallpox Vaccine Market Drivers
8.3 Smallpox Vaccine Market Challenges
8.4 Smallpox Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bavarian Nordic
CEL-SCI
Chimerix
EpiVax
Nanotherapeutics Inc
Oncovir Inc
SIGA Technologies
Symphogen
TapImmune
Tonix Pharmaceuticals Holding
List of Tables
 Table 1. Global Smallpox Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Smallpox Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Smallpox Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Smallpox Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Smallpox Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Smallpox Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Smallpox Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Smallpox Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Smallpox Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Smallpox Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Smallpox Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Smallpox Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Smallpox Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Smallpox Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Smallpox Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Smallpox Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Smallpox Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Smallpox Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Smallpox Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Smallpox Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Smallpox Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Smallpox Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Smallpox Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Smallpox Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Smallpox Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Smallpox Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Smallpox Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Smallpox Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Smallpox Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Smallpox Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Smallpox Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Smallpox Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Smallpox Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Smallpox Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Smallpox Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Smallpox Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Smallpox Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Smallpox Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Smallpox Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Smallpox Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Smallpox Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Smallpox Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Smallpox Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Smallpox Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Smallpox Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Smallpox Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Smallpox Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Smallpox Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Smallpox Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Smallpox Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Smallpox Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Smallpox Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Smallpox Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Smallpox Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Smallpox Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Smallpox Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Smallpox Vaccine Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Smallpox Vaccine Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Smallpox Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Smallpox Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Smallpox Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Smallpox Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Smallpox Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Smallpox Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Smallpox Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Smallpox Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Smallpox Vaccine Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Smallpox Vaccine Price (USD/Unit) by Application (2026-2031)
 Table 70. Bavarian Nordic Company Information
 Table 71. Bavarian Nordic Description and Business Overview
 Table 72. Bavarian Nordic Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Bavarian Nordic Smallpox Vaccine Product
 Table 74. Bavarian Nordic Recent Developments/Updates
 Table 75. CEL-SCI Company Information
 Table 76. CEL-SCI Description and Business Overview
 Table 77. CEL-SCI Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. CEL-SCI Smallpox Vaccine Product
 Table 79. CEL-SCI Recent Developments/Updates
 Table 80. Chimerix Company Information
 Table 81. Chimerix Description and Business Overview
 Table 82. Chimerix Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Chimerix Smallpox Vaccine Product
 Table 84. Chimerix Recent Developments/Updates
 Table 85. EpiVax Company Information
 Table 86. EpiVax Description and Business Overview
 Table 87. EpiVax Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. EpiVax Smallpox Vaccine Product
 Table 89. EpiVax Recent Developments/Updates
 Table 90. Nanotherapeutics Company Information
 Table 91. Nanotherapeutics Description and Business Overview
 Table 92. Nanotherapeutics Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Nanotherapeutics Smallpox Vaccine Product
 Table 94. Nanotherapeutics Recent Developments/Updates
 Table 95. Oncovir Company Information
 Table 96. Oncovir Description and Business Overview
 Table 97. Oncovir Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Oncovir Smallpox Vaccine Product
 Table 99. Oncovir Recent Developments/Updates
 Table 100. SIGA Technologies Company Information
 Table 101. SIGA Technologies Description and Business Overview
 Table 102. SIGA Technologies Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. SIGA Technologies Smallpox Vaccine Product
 Table 104. SIGA Technologies Recent Developments/Updates
 Table 105. Symphogen Company Information
 Table 106. Symphogen Description and Business Overview
 Table 107. Symphogen Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Symphogen Smallpox Vaccine Product
 Table 109. Symphogen Recent Developments/Updates
 Table 110. TapImmune Company Information
 Table 111. TapImmune Description and Business Overview
 Table 112. TapImmune Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. TapImmune Smallpox Vaccine Product
 Table 114. TapImmune Recent Developments/Updates
 Table 115. Tonix Pharmaceuticals Holding Company Information
 Table 116. Tonix Pharmaceuticals Holding Description and Business Overview
 Table 117. Tonix Pharmaceuticals Holding Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Tonix Pharmaceuticals Holding Smallpox Vaccine Product
 Table 119. Tonix Pharmaceuticals Holding Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Smallpox Vaccine Distributors List
 Table 123. Smallpox Vaccine Customers List
 Table 124. Smallpox Vaccine Market Trends
 Table 125. Smallpox Vaccine Market Drivers
 Table 126. Smallpox Vaccine Market Challenges
 Table 127. Smallpox Vaccine Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Smallpox Vaccine
 Figure 2. Global Smallpox Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Smallpox Vaccine Market Share by Type: 2024 & 2031
 Figure 4. First Generation Product Picture
 Figure 5. Second Generation Product Picture
 Figure 6. Third Generation Product Picture
 Figure 7. Global Smallpox Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Smallpox Vaccine Market Share by Application: 2024 & 2031
 Figure 9. Government Hospital And Program
 Figure 10. Private Hospitals / Clinicss
 Figure 11. Global Smallpox Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Smallpox Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Smallpox Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global Smallpox Vaccine Average Price (USD/Unit) & (2020-2031)
 Figure 15. Smallpox Vaccine Report Years Considered
 Figure 16. Smallpox Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global Smallpox Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Smallpox Vaccine Players: Market Share by Revenue in Smallpox Vaccine in 2024
 Figure 19. Smallpox Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Smallpox Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Smallpox Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America Smallpox Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Smallpox Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Smallpox Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Smallpox Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Smallpox Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Smallpox Vaccine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Smallpox Vaccine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Smallpox Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Smallpox Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Smallpox Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Smallpox Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Smallpox Vaccine by Type (2020-2031)
 Figure 56. Global Smallpox Vaccine Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Smallpox Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Smallpox Vaccine by Application (2020-2031)
 Figure 59. Global Smallpox Vaccine Price (USD/Unit) by Application (2020-2031)
 Figure 60. Smallpox Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Monkeypox Virus Vaccine Market Research Report 2024
Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Seasonal Vaccines Market Research Report 2024
Monkeypox Vaccine And Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccination Device Market Research Report 2024
Global Smallpox Treatment Market Insights Forecast to 2030
Global Adult Vaccines Market Research Report 2024
Global Combination Vaccine and Multivalent Vaccine Market Research Report 2024
Global Vaccines for the Elderly Market Research Report 2024
Global Tetanus Toxoid Vaccine Market Research Report 2024
Global Live Vaccines Market Research Report 2024
Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024
Global DNA Vaccination Market Research Report 2024
Global Vaccines For Cattle And Sheep Market Research Report 2024
Coronavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chickenpox Varicella Vaccine Market
Global Poultry Viral Disease Vaccines Market Research Report 2024
Global Multiple Vaccine Market Research Report 2024
Global Consumption Type Vaccine Market Research Report 2024
Global Norovirus Vaccine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions